Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses
Accumulating evidence support an important role for endogenous bystander dendritic cells (DCs) in the efficiency of autologous patient-derived DC-vaccines, as bystander DCs take up material from vaccine-DCs, migrate to draining lymph node and initiate antitumor T-cell responses. We examined the poss...
Main Authors: | Grammatiki Fotaki, Chuan Jin, Mohanraj Ramachandran, Iliana Kyriaki Kerzeli, Alex Karlsson-Parra, Di Yu, Magnus Essand |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-03-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1395126 |
Similar Items
-
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
by: Grammatiki Fotaki, et al.
Published: (2018-03-01) -
Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
by: Chuan Jin, et al.
Published: (2022-12-01) -
Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis
by: Jun Zhao, et al.
Published: (2021-01-01) -
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
by: Magnus Rizell, et al.
Published: (2019-01-01) -
IL-10-Engineered Dendritic Cells Modulate Allogeneic CD8<sup>+</sup> T Cell Responses
by: Marta Fortunato, et al.
Published: (2023-05-01)